Columnar mucosa and intestinal metaplasia of the esophagus: Fifty years of controversy

Annals of Surgery

Volumn 231, Issue 3, 2000, Pages 303-321

  DeMeester, Steven R ^a,b   DeMeester, Tom R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; ESOPHAGUS RESECTION; FOLLOW UP; GASTROESOPHAGEAL REFLUX; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PRIORITY JOURNAL; REVIEW;

BARRETT ESOPHAGUS; CARDIA; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS; INTESTINES; METAPLASIA; MUCOUS MEMBRANE; STOMACH ULCER;

EID: 0034090989     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200003000-00003     Document Type: Review

References (100)

1. Barrett N. Chronic peptic ulcer of the oesophagus and 'oesophagitis.' Br J Surg 1950; 38:175-182.
2. Allison P, Johnstone A. The oesophagus lined with gastric mucous membrane. Thorax 1953; 8:87-101.
3. Barrett M. The lower esophagus lined by columnar epithelium. Surgery 1957; 41:881-894.
4. Moersch R, Ellis F, McDonald JR. Pathologic changes occurring in severe reflux esophagitis. Surg Gynecol Obstet 1959; 108:476-484.
5. Bremner CG, Lynch VP, Ellis HF. Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1970; 68:209-216.
6. Hayward J. The lower end of the esophagus. Thorax 1961; 16:36-41.
7. Bosher L, Taylor F. Heterotopic gastric mucosa in the esophagus with ulceration and stricture formation. J Thorac Surg 1951; 21:306-312.
8. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976; 295:476-80.
9. Haggitt RC, Tryzelaar J, Ellis FH, Colcher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 1978; 70:1-5.
10. Skinner DB, Walther BC, Riddell RH, Schmidt H, lascone C, De-Meester TR. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983; 198:554-65.
11. Reid BJ, Weinstein WM. Barrett's esophagus and adenocarcinoma [review]. Ann Rev Med 1987; 38:477-492.
12. Clark GW, Ireland AP, Peters JH, Chandrasoma P, DeMeester TR, Bremner CG. Short-segment Barrett's esophagus: a prevalent complication of gastroesophageal reflux disease with malignant potential. J Gastrointest Surg 1997; 1:113-122.
13. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998; 93:1028-1032.
14. Phillips RW, Wong RK. Barrett's esophagus. Natural history, incidence, etiology, and complications [review]. Gastroenterol Clin North Am 1991; 20:791-816.
15. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma [review]. Gastroenterol Clin North Am 1997; 26:487-494.
16. Cameron AJ, Zinsmeister AR. Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99:918-922.
17. Eisen GM, Sandler RSm Murray S, Gottfried M. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol 1997; 92:27-31.
18. Clark GW, Ireland AP, DeMeester TR. Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment [review]. Dig Dis 1996; 14:213-27.
19. Stein HJ, Hoeft S, DeMeester TR. Functional t'oregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg 1993; 105:107-111.
20. Singh P, Taylor RH, Colin-Jones DG. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Am J Gastroenterol 1994; 89:349-356.
21. Meyer W, Vollmar F, Bar W. Barrett-esophagus following total gastrectomy. A contribution to its pathogenesis. Endoscopy 1979; 11:121-126.
22. Oberg S, Ritter MP, Crookes PF, et al. Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal reflux. J Gastrointest Surg 1998; 2:547-554.
23. Fein M, Ireland AP, Ritter MP, et al. Duodenogastric reflux potentiates the injurious effects of gastroesophageal reflux. J Gastrointest Surg 1997; 1:27-33.
24. Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol 1996; 91:1532-1538.
25. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995; 222:525-533.
26. Chandrasoma P. Pathophysiology of Barrett's esophagus. Semin Thorac Cardiovasc Surg 1997; 9:270-278.
27. Lindahl H, Rintala R, Sariola H, Louhimo I. Cervical Barrett's esophagus: a common complication of gastric tube reconstruction. J Pediatr Surg 1990; 25:446-448.
28. Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997; 226:522-532.
29. Mason RJ, Oberg S, Bremner CG, et al. Postprandial gastroesophageal reflux in normal volunteers and symptomatic patients. J Gastrointest Surg 1998; 2:342-349.
30. Csendes A, Maluenda F, Braghetto I, Csendes P, Henriquez A, Quesada MS. Location of the lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis. Gut 1993; 34:21-27.
31. DeMeester TR, Ireland AP. Gastric pathology as an initiator and potentiator of gastroesophageal reflux disease [review]. Dis Esoph 1997; 10:1-8.
32. Spechler S, Zeroogian J, Wand H, Antonioli D, Goyal R. The frequency of specialized intestinal metaplasia at the squamo-columnar junction varies with the extent of columnar epithelium lining the esophagus. Gastroenterology 1995; 108:A224.
33. Mendes de Almeida JC, Chaves P, Pereira AD, Altorki NK. Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study. Ann Surg 1997; 226: 725-735.
34. Griffel L, Weston A, Karalnik N, Amenta P, Das K. Early diagnosis of short-segment Barrett's esophagus (SSBE) using an immunohistochemical marker: an inter-institutional blinded study. Gastroenterology 1998; 114:A140.
35. Fitzgerald RC, Omary MB. Triadafilopoulos G. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J Clin Invest 1996; 98:2120-2128.
36. Oberg S, DeMeester TR, Peters JH, et al. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg 1999; 117:572-580.
37. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998; 114:633-639.
38. Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalovski M. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus. Dig Dis Sci 1997; 42:597-602.
39. Nandurkar S, Talley NJ, Martin CJ, Ng TH, Adams S. Short-segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 1997; 40:710-715.
40. Morales TG, Bhattacharyya A, Johnson C, Sampliner RE. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?. Am J Gastroenterol 1997; 92:1818-1822.
41. Pereira AD, Suspiro A, Chaves P, et al. Short segments of Barrett's epithelium and intestinal metaplasia in normal-appearing oesophagogastric junctions: the same or two different entities? Gut 1998; 42:659-662.
42. Cooper JE, Spitz L, Wilkins BM. Barrett's esophagus in children: a histologic and histochemical study of 11 cases. J Pediatr Surg 1987; 22:191-196.
43. Hassall E, Weinstein WM. Partial regression of childhood Barrett's esophagus after fundoplication. Am J Gastroenterol 1992; 87:1506-1512.
44. Hoeffel JC, Nihoul-Fekete C, Schmitt M. Esophageal adenocarcinoma after gastroesophageal reflux in children [published erratum appears in J Pediatr 1989 Nov;115(5 Pt 1):836]. J Pediatr 1989; 115:259-261.
45. Qualman SJ, Murray RD, McClung HJ, Lucas J. Intestinal metaplasia is age related in Barrett's esophagus. Arch Pathol Lab Med 1990; 114:1236-1240.
46. Hamilton SR, Yardley JH. Regeneration of cardiac-type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology 1977; 72:669-675.
47. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992; 103:1241-1245.
48. Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994; 89:670-680.
49. Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol 1995; 175:175-180.
50. Menke-Pluymers MB, Mulder AH, Hop WC, van Blankenstein M, Tilanus HW. Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group. Gut 1994; 35:1348-1351.
51. Rice TW, Goldblum JR, Falk GW, Tubbs RR, Kirby TJ, Casey G. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma. J Thorac Cardiovasc Surg 1994; 108:1132-1137.
52. Krishnadath KK, Tilanus HW, van Blankenstein M, et al. Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus. Cancer Res 1995; 55:1971-1976.
53. Cameron AJ, Carpenter HA. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 1997; 92:586-591.
54. McClave SA, Boyce HW Jr, Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopie diagnostic criterion. Gastrointest Endosc 1987; 33:413-416.
55. Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108:813-822.
56. van Sandick JW, van Lanschot JJB, Kuiken BW, Tytgat GNJ, Offerhaus GJA, Obertop H. Impact of endoscopie biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998; 43:216-222.
57. Streitz JM Jr, Ellis FH Jr, Tilden RL, Erickson RV. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol 1998; 93:911-915.
58. Sampliner RE. Effect of up to 3 years of high-dose lanisoprazole on Barrett's esophagus. Am J Gastroenterol 1994; 89:1844-1848.
59. Katzka DA, Castell DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994; 89:989-991.
60. Peghini PL, Katz PO, Bracy NA, Caslell DO. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 1998; 93:763-767.
61. Shaffer R, Francis J, Carrougher J, Kadakia S. Effect of omeprazole on Barrett's epithelium after 3 years of therapy. Gastroenterology 1996; 110:A255.
62. Ortiz A, Martinez de Haro LF, Parrilla P, et al. Conservative treatment versus antireflux Surg in Barrett's oesophagus: long-term results of a prospective study. Br J Surg 1996; 83:274-278.
63. Sampliner RE, Garewal HS, Fennerty MB, Aickin M. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 1990; 35:93-96.
64. Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalovski M. Prospective long-term endoscopie and histological follow-up of short-segment Barrett's esophagus: comparison with traditional long-segment Barrett's esophagus. Am J Gastroenterol 1997; 92: 407-413.
65. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340:825-831.
66. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96:1249-1256.
67. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 1997; 92:2012-2016.
68. Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 1992; 326:786-792.
69. Brand DL, Ylvisaker JT, Gelfand M, Pope CE 2d. Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery. N Engl J Med 1980; 302:844-848.
70. DeMeester TR, Attwood SE, Smyrk TC, Therkildsen DH, Hinder RA. Surgical therapy in Barrett's esophagus. Ann Surg 1990; 212: 528-542.
71. Sagar PM, Ackroyd R, Hosie KB, Patterson JE, Stoddard CJ, Kingsnorth AN. Regression and progression of Barrett's oesophagus after antireflux surgery. Br J Surg 1995; 82:806-810.
72. Radigan LR, Glover JL, Shipley FE, Shoemaker RE. Barrett esophagus. Arch Surg 1977; 112:486-491.
73. Ransom JM, Patel GK, Clift SA, Womble NE, Read RC. Extended and limited types of Barrett's esophagus in the adult. Ann Thorac Surg 1982; 33:19-27.
74. Starnes VA, Adkins RB, Ballinger JF, Sawyers JL. Barrett's esophagus. A surgical entity. Arch Surg 1984; 119:563-567.
75. Williamson WA, Ellis FH Jr, Gibb SP, Shahian DM, Aretz HT. Effect of antireflux operation on Barrett's mucosa. Ann Thorac Surg 1990; 49:537-542.
76. Attwood SE, Barlow AP, Norris TL, Watson A. Barrett's oesophagus: effect of antireflux surgery on symptom control and development of complications. Br J Surg 1992; 79:1050-1053.
77. McDonald ML, Trastek VF, Allen MS, Deschamps C, Pairolero PC, Pairolero PC. Barrett's esophagus: does an antireflux procedure reduce the need for endoscopie surveillance?. J Thorac Cardiovasc Surg 1996; 111:1135-1140.
78. DeMeester SR, Campos GM, DeMeester TR, et al. The impact of an antireflux procedure on intestinal metaplasia of the cardia. Ann Surg 1998; 228:547-556.
79. Low DE, Levine DS, Dail DH, Kozarek RA. Histological and anatomic changes in Barrett's esophagus after antireflux surgery. Am J Gastroenterol 1999; 94:80-85.
80. McCallum R, Polepalle S, Davenport K, Frierson H, Boyd S. Role of anti-reflux surgery against dysplasia in Barrett's esophagus. Gastroenterology 1991; 100:A121.
81. Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 1998; 93: 536-541.
82. Pearson FG, Cooper JD, Patterson GA, Prakash D. Peptic ulcer in acquired columnar-lined esophagus: results of surgical treatment. Ann Thoracic Surg 1987; 43:241-244.
83. Naef AP, Savary M, Ozzello L. Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 1975; 70:826-835.
84. Smith R, Hamilton S, Boitnott J, Rogers E. Spectrum of carcinoma arising in Barrett's esophagus: a clinicopathologic study of twentyfive patients. Lab Invest 1982; 17:78A.
85. Levine MS, Caroline D, Thompson JJ, Kressel HY, Laufer I, Herlinger H. Adenocarcinoma of the esophagus: relationship to Barrett mucosa. Radiology 1984; 150:305-309.
86. Salo JA, Salminen JT, Kiviluoto TA, et al. Treatment of Barrett's esophagus by endoscopie laser ablation and antireflux surgery. Ann Surg 1998; 227:40-44.
87. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999; 49:1-7.
88. Bremner RM, Mason RJ, Bremner CG, et al. Ultrasonic epithelial ablation of the lower esophagus without stricture formation. A new technique for Barrett's ablation. Surg Endosc 1998; 12:342-347.
89. Levine D, Haggitt R, Irvine S, Reid B. Natural history of high-grade dysplasia in Barrett's esophagus. Gastroenterology 1996; 110:A550.
90. Schnell T, Sontag S, Chejfec G, et al. High-grade dysplasia (HGD) is not an indication for surgery in patients with Barrett's esophagus. Gastroenterology 1996; 110:A590.
91. Williamson WA, Ellis FH Jr, Gibb SP, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151:2212-2216.
92. Ortiz-Hidalgo C, De La Vega G, Aguirre-Garcia J. The histopathologic and biologic prognostic factors of Barrett's esophagus: a review. J Clin Gastroenterol 1998; 26:324-333.
93. van Lieshout EM, Roelofs HM, Dekker S, et al. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res 1999; 59:586-589.
94. Klump B, Hsieh CJ, Holzmann K, Gregor M, Porschen R. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterology 1998; 115:1381-1386.
95. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998; 58: 2929-2934.
96. Ferguson MK, Naunheim KS. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 1997; 114:824-829.
97. Messmann H, Endlicher E, Knoechel R, Schoelmerich J. Endoscopic fluorescence detection of high- and low-grade dysplasia in Barrett's esophagus after sensitization with 5-amino levulinic acid [abstract]. American Gastroenterological Association Poster Session, Digestive Diseases Week, Orlando, Florida, May 16-19, 1999.
98. Haringsma J, Prawirodirdjo W, Tytgat G. Accuracy of fluorescence imaging of dysplasia in Barrett's esophagus [abstract]. American Gastroenterological Association Research Forum, Digestive Diseases Week, Orlando, Florida, May 16-19, 1999.
99. Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999; 117:16-25.
100. Nigro JJ, Hagen JA, DeMeester TR, et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 1999; 230:433-440.